Objective: Some studies suggest better outcomes with macrolide therapy for critically ill
patients with community-acquired pneumonia. To further explore this, we performed a …

Community-acquired pneumonia (CAP) is an increasing problem among the elderly.
Multiple factors related to ageing, such as comorbidities, nutritional status and swallowing …

Los antimicrobianos son fármacos distintos al resto. Su eficacia en la reducción de la
morbilidad y la mortalidad es muy superior a la de otros grupos de medicamentos. Por otra …

This article describes the systematic development of a set of generic quality indicators to
meet an important requirement for an effective stewardship program: the ability to measure …

Community-acquired pneumonia is diagnosed by clinical features (eg, cough, fever, pleuritic
chest pain) and by lung imaging, usually an infiltrate seen on chest radiography. Initial …

Community-acquired pneumonia (CAP) is defined as an acute symptomatic infection of the
lower respiratory tract which in general develops outside of a hospital or nursing home …

Community-acquired pneumonia (CAP) can occur at any time of life, but its incidence and
risk of death are linked to increasing age. CAP in the elderly is a major health problem …

Background. Macrolides are used to treat pneumonia despite increasing antimicrobial
resistance. However, the immunomodulatory properties of macrolides may have a favorable …

Very old (aged≥ 80 years) adults constitute an increasing proportion of the global
population. Currently, this subgroup of patients represents an important percentage of …

Background Hospital length of stay (LOS) and time for a patient to reach clinical stability
(TCS) have increasingly become important outcomes when investigating ways in which to …